2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The evidence for chronic hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC) occurrence is well established. The hepatocyte epithelium carcinogenesis caused by HBV has been investigated and reviewed in depth. Nevertheless, recent findings from preclinical and observational studies suggested that chronic HBV infection is equally important in extrahepatic cancer occurrence and survival, specifically gastrointestinal system-derived cancers. Immune microenvironment changes (immune-suppressive cytokine infiltration), epigenetic modification (N6-methyladenosine), molecular signaling pathways (PI3K–Akt and Wnt), and serum biomarkers such as hepatitis B virus X (HBx) protein are potential underlying mechanisms in chronic HBV infection-induced extrahepatic cancers. This narrative review aimed to comprehensively summarize the most recent advances in evaluating the association between chronic HBV infection and extrahepatic cancer risk and explore the potential underlying molecular mechanisms in the carcinogenesis induction of extrahepatic cancers in chronic HBV conditions.

          Related collections

          Most cited references191

          • Record: found
          • Abstract: found
          • Article: not found

          Hallmarks of Cancer: New Dimensions

          The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity of cancer phenotypes and genotypes into a provisional set of underlying principles. As knowledge of cancer mechanisms has progressed, other facets of the disease have emerged as potential refinements. Herein, the prospect is raised that phenotypic plasticity and disrupted differentiation is a discrete hallmark capability, and that nonmutational epigenetic reprogramming and polymorphic microbiomes both constitute distinctive enabling characteristics that facilitate the acquisition of hallmark capabilities. Additionally, senescent cells, of varying origins, may be added to the roster of functionally important cell types in the tumor microenvironment. SIGNIFICANCE: Cancer is daunting in the breadth and scope of its diversity, spanning genetics, cell and tissue biology, pathology, and response to therapy. Ever more powerful experimental and computational tools and technologies are providing an avalanche of "big data" about the myriad manifestations of the diseases that cancer encompasses. The integrative concept embodied in the hallmarks of cancer is helping to distill this complexity into an increasingly logical science, and the provisional new dimensions presented in this perspective may add value to that endeavor, to more fully understand mechanisms of cancer development and malignant progression, and apply that knowledge to cancer medicine.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Nasopharyngeal carcinoma

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

              The Lancet, 385(9963), 117-171
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                01 March 2023
                2023
                : 14
                : 1141956
                Affiliations
                [1] 1 Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University , Sichuan, China
                [2] 2 Department of Head and Neck Oncology, Department of Radiation Oncology, Cancer Center, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University , Sichuan, China
                [3] 3 Research and Development Department Shanghai ETERN Biopharma Co., Ltd. , Shanghai, China
                [4] 4 West China School of Nursing, West China Hospital, Sichuan University , Sichuan, China
                Author notes

                Edited by: Sha Wu, Southern Medical University, China

                Reviewed by: Azam Roohi, Tehran University of Medical Sciences, Iran; Zhinan Yin, Jinan University, China

                *Correspondence: Xingchen Peng, pxx2014@ 123456163.com ; Xiaolin Hu, huxiaolin@ 123456wchscu.cn

                †These authors have contributed equally in this work

                This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology

                Article
                10.3389/fimmu.2023.1141956
                10014788
                36936956
                0f0b8d10-0f75-4449-9ce6-3de761187394
                Copyright © 2023 Min, Wei, Xia, Wei, Li, Jin, Liu, Hu and Peng

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 11 January 2023
                : 20 February 2023
                Page count
                Figures: 4, Tables: 2, Equations: 0, References: 191, Pages: 20, Words: 10069
                Funding
                Funded by: National Key Research and Development Program of China , doi 10.13039/501100012166;
                Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
                The work was supported by the National Key Research and Development Program of China (2021YFE0206600), the National Natural Science Foundation of China (82172842 and 81672386), the Sichuan Province Science and Technology Support grant, and Tianfu Laboratory (2022SYSX0064, 2021YFSY0008, 2020YFS0276), West China Nursing Discipline Development Special Fund Project (HXHL21008). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.
                Categories
                Immunology
                Review

                Immunology
                hepatitis b virus,extrahepatic cancer,immune microenvironment,risk factor,molecular mechanisms

                Comments

                Comment on this article